Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Celularity, Inc. (CELU) vs 4D pharma PLC Sponsored ADR (LBPS)

Celularity, Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. Celularity, Inc. and 4D pharma PLC Sponsored ADR are of similar size ($38.2M and $37.2M). Celularity, Inc. has the higher net margin (−345.8% vs −9,577.1%) and the lower return on invested capital (−1,070.9% vs 0.00%). Across the 16 metrics below, Celularity, Inc. leads on 9 and 4D pharma PLC Sponsored ADR on 7.

Valuation

Metric CELU LBPS Biotechnology median
P/E n/m n/m 7.88
P/S 1.33 211.23 11.47
P/B n/m 9.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.90 205.89 10.73
Earnings yield (259.89%) (40.76%) (28.84%)
Free cash flow yield (37.97%) (30.32%) (23.03%)

Profitability

Metric CELU LBPS Biotechnology median
Gross margin 24.39% 0.00% 65.16%
Operating margin (230.92%) 0.00% 0.00%
Net margin (345.76%) (9,577.06%) 0.00%
Free cash flow margin (49.92%) (6,318.73%) 0.00%
Return on equity 628.23% (742.15%) (57.72%)
Return on assets (76.50%) (371.23%) (49.22%)
Return on invested capital (1,070.92%) 0.00% 0.00%

Growth

Metric CELU LBPS Biotechnology median
Revenue growth (TTM) (51.03%) — 5.64%
EPS growth (last fiscal year) (35.71%) 35.04% —
Revenue growth, 5-year CAGR 13.21% 21.70% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELU LBPS Biotechnology median
Debt to equity (1.26) 0.43 0.00
Current ratio 0.15 5.21 4.73
Net debt to EBITDA (0.77) 0.23 0.96

Dividend

Metric CELU LBPS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CELU LBPS Biotechnology median
Market cap 38.21m 37.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack